Endometrial Cancer After Breast Cancer Treatment
Author Information
Author(s): M. Ewertz, S.G. Machado, J.D. Boice, Jr., O.M. Jensen
Primary Institution: Danish Cancer Registry, Institute of Cancer Epidemiology under the Danish Cancer Society
Hypothesis
What is the risk of developing endometrial cancer after being treated for breast cancer?
Conclusion
The study found that certain factors, such as menopausal estrogen use and nulliparity, significantly increase the risk of developing endometrial cancer in women who have had breast cancer.
Supporting Evidence
- Women who used menopausal oestrogens had a relative risk of 4.9 for developing endometrial cancer.
- Nulliparous women had a relative risk of 2.1 compared to those who had children.
- Late age at natural menopause was associated with a relative risk of 2.9.
Takeaway
Women who had breast cancer might get endometrial cancer later, especially if they never had kids or used certain hormones.
Methodology
A case-control study was conducted using data from the Danish Cancer Registry, comparing women with endometrial cancer to matched controls without subsequent malignancies.
Potential Biases
Potential overmatching on common risk factors could underestimate the true associations.
Limitations
The study size was small, which limited the ability to draw conclusive evaluations about the risks associated with hormones or pelvic radiation.
Participant Demographics
Women diagnosed with breast cancer between 1943-1977 in Denmark.
Statistical Information
P-Value
0.018
Confidence Interval
95% CI: 2.0-12
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website